EDAP TMS S.A. (FOCL) vs InMode (INMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
EDAP TMS S.A. (FOCL) has outperformed InMode (INMD) over the past year, gaining 86.7% versus a loss of 6.4%. Over five years, FOCL leads with a -31.8% price change compared with -83.1% for INMD. InMode is the larger company by market cap ($810.2 million vs $194.8 million), about 4.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FOCL | INMD |
|---|---|---|
| Share price | $4.13 | $14.08 |
| Market cap | $194.77M | $810.22M |
| 1-day change | -1.55% | +0.50% |
| YTD return | +25.38% | -4.15% |
| 1-year return | +86.65% | -6.45% |
| 5-year return | -31.82% | -83.11% |
| P/E ratio (TTM) | — | 11.54 |
| Forward P/E | — | 10.26 |
| EPS (TTM) | $-1.39 | $1.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.40 | $16.67 |
| 52-week low | $1.75 | $12.72 |
| Distance from 52-week high | -35.55% | -15.54% |
| Analyst consensus | buy | none |
| Avg. price target upside | +113.33% | +14.84% |
| Average volume | 114.80K | 501.37K |
| Shares outstanding | 47.22M | 57.54M |
| Employees | 289 | 660 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- InMode is about 4.2 times larger than EDAP TMS S.A. by market value ($810.22M vs $194.77M).
- FOCL has outperformed INMD by 93.1 percentage points over the past year.
About EDAP TMS S.A.
FOCL stock →EDAP TMS S.A., doing business as FocalTherics, operates as a medical technology company that develops, manufactures, markets, and sells non-invasive therapeutic ultrasound and energy-based medical devices in Asia, France, the United States, and internationally. The company develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 289 employees
About InMode
INMD stock →InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 660 employees
FOCL vs INMD FAQ
Which is bigger, EDAP TMS S.A. or InMode?
InMode (INMD) is larger, with a market capitalization of $810.22M compared with $194.77M for EDAP TMS S.A. (FOCL).
Which stock has performed better over the past year, FOCL or INMD?
FOCL returned +86.65% over the past 12 months, compared with -6.45% for INMD (price return, excluding dividends). Past performance does not predict future results.
Are EDAP TMS S.A. and InMode in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.